Additive channels

US10228381B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10228381-B2
Application numberUS-201715648085-A
CountryUS
Kind codeB2
Filing dateJul 12, 2017
Priority dateJul 12, 2016
Publication dateMar 12, 2019
Grant dateMar 12, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

First claim

Opening claim text (preview).

The invention claimed is: 1. A microfluidic device, comprising: an input port; an output port; a test channel, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port; endothelial cells disposed within at least one portion of said test channel; and an input additive channel, wherein said input additive channel is in fluidic communication with said input portion of said test channel, and wherein said input additive channel is configured to deliver fluid to at least two opposing sides of said input portion of said test channel. 2. The device of claim 1 , wherein said endothelial cells are living. 3. The device of claim 1 , wherein said endothelial cells are fixed. 4. The device of claim 1 , wherein said input additive channel is configured to deliver fluid to at least two opposing sides of said input portion at or near said input port. 5. The device of claim 1 wherein said input additive channel divides into two or more additive channel branches, wherein said two or more additive channel branches are configured to produce an approximately equal fluidic resistance. 6. The device of claim 1 , further comprising an output additive channel in fluidic communication with said output portion of said test channel. 7. The device of claim 1 , further comprising a porous membrane and a back channel, wherein said membrane is situated between at least one portion of said test channel and at least one portion of said back channel. 8. The device of claim 7 , wherein at least one non-endothelial cell type is disposed within at least one portion of said back channel. 9. The device of claim 1 , wherein said input additive channel further comprises a fluidic resistor. 10. The device of claim 6 , wherein said output additive channel further comprises a fluidic resistor. 11. A microfluidic device, comprising: an input port; an output port; a test channel, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port; endothelial cells disposed within at least one portion of said test channel; and an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel, and wherein said output additive channel is configured to deliver fluid to at least two opposing sides of said output portion of said test channel. 12. The device of claim 11 , wherein said endothelial cells are living. 13. The device of claim 11 , wherein said endothelial cells are fixed. 14. The device of claim 11 , wherein said output additive channel is configured to deliver fluid to at least two opposing sides of said output portion at or near said output port. 15. The device of claim 11 , wherein said output additive channel divides into two or more additive channel branches, wherein said two or more additive channel branches are configured to produce an approximately equal fluidic resistance. 16. The device of claim 11 , further comprising an input additive channel in fluidic communication with said input portion of said test channel. 17. The device of claim 11 , further comprising a porous membrane and a back channel, wherein said membrane is situated between at least one portion of said test channel and at least one portion of said back channel. 18. The device of claim 17 , wherein at least one non-endothelial cell type is disposed within at least one portion of said back channel. 19. The device of claim 11 , wherein said output additive channel further comprises a fluidic resistor. 20. The device of claim 16 , wherein said input additive channel further comprises a fluidic resistor. 21. A microfluidic device, comprising: an input port; an output port; a test channel comprising surfaces, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port; endothelial cells disposed within said test channel and covering all of said surfaces of said test channel so as to make a lumen; an input additive channel, wherein said input additive channel is in fluidic communication with said input portion of said test channel. 22. The device of claim 21 , wherein said endothelial cells are living. 23. The device of claim 21 , further comprising an output additive channel in fluidic communication with said output portion of said test channel. 24. The device of claim 21 , further comprising an input channel in fluidic communication with said input portion of said test channel. 25. The device of claim 21 , further comprising and output channel in fluidic communication with output portion of said test channel. 26. A microfluidic device, comprising: an input port; an output port; a test channel comprising surfaces, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port; endothelial cells disposed within said test channel and covering all of said surfaces of said test channel so as to make a lumen; and an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel. 27. The device of claim 24 , wherein said endothelial cells are living. 28. The device of claim 24 , further comprising an input additive channel in fluidic communication with said input portion of said test channel. 29. The device of claim 26 , further comprising an input channel in fluidic communication with said input portion of said test channel. 30. The device of claim 26 , further comprising and output channel in fluidic communication with output portion of said test channel.

Assignees

Inventors

Classifications

  • characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

  • Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title

  • Multiple inlets and one sample wells, e.g. mixing, dilution · CPC title

  • for microfluidic devices · CPC title

  • characterised by the manufacture of the container or its components · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10228381B2 cover?
Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or mor…
Who is the assignee on this patent?
Emulate Inc, Janssen Biotech Inc
What technology area does this patent fall under?
Primary CPC classification B01L3/502746. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).